CIBCX | FCGBX | CIBCX / FCGBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 13 years | - |
Gain YTD | 6.508 | 0.096 | 6,784% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 105B | 292M | 35,959% |
Annual Yield % from dividends | 2.54 | 2.95 | 86% |
Returns for 1 year | 7.50 | 0.91 | 824% |
Returns for 3 years | 6.31 | -2.51 | -252% |
Returns for 5 years | 19.45 | -5.13 | -379% |
Returns for 10 years | 28.06 | -3.92 | -716% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 32.60 | 0.46 | +1.43% |
Eventide Healthcare & Life Sciences A | |||
GSVTX | 15.86 | 0.18 | +1.15% |
Goldman Sachs Large Cap Value Inv | |||
FCDIX | 37.57 | 0.22 | +0.59% |
Fidelity Advisor Stock Selector Sm Cp I | |||
NUIAX | 27.96 | -0.10 | -0.36% |
Nuveen International Dividend Growth A | |||
JHJAX | 22.95 | -1.97 | -7.92% |
JHancock ESG Large Cap Core A |